Literature DB >> 19870362

THE SEROLOGICAL DIFFERENTIATION OF PATHOGENIC AND NON-PATHOGENIC STRAINS OF HEMOLYTIC STREPTOCOCCI FROM PARTURIENT WOMEN.

R C Lancefield1, R Hare.   

Abstract

1. The majority of strains of hemolytic streptococci from puerperal infections of the uterus were identified serologically as members of the Group A described by Lancefield. 2. The majority of strains isolated from the birth canal of women whose puerperium was afebrile were not members of Group A. 3. The existence of two new serological groups of hemolytic streptococci, Groups F and G, is described.

Entities:  

Year:  1935        PMID: 19870362      PMCID: PMC2133228          DOI: 10.1084/jem.61.3.335

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  7 in total

1.  THE SOURCE OF INFECTION IN A MINOR OUTBREAK OF PUERPERAL FEVER.

Authors:  C G Paine
Journal:  Br Med J       Date:  1931-12-12

2.  FIBRINOLYTIC ACTIVITY OF HEMOLYTIC STREPTOCOCCI. THE DEVELOPMENT OF RESISTANCE TO FIBRINOLYSIS FOLLOWING ACUTE HEMOLYTIC STREPTOCOCCUS INFECTIONS.

Authors:  W S Tillett; L B Edwards; R L Garner
Journal:  J Clin Invest       Date:  1934-01       Impact factor: 14.808

3.  STUDIES UPON MINUTE HEMOLYTIC STREPTOCOCCI : I. THE ISOLATION AND CULTURAL CHARACTERISTICS OF MINUTE BETA HEMOLYTIC STREPTOCOCCI.

Authors:  P H Long; E A Bliss
Journal:  J Exp Med       Date:  1934-10-31       Impact factor: 14.307

4.  THE FIBRINOLYTIC ACTIVITY OF HEMOLYTIC STREPTOCOCCI.

Authors:  W S Tillett; R L Garner
Journal:  J Exp Med       Date:  1933-09-30       Impact factor: 14.307

5.  STUDIES UPON MINUTE HEMOLYTIC STREPTOCOCCI : II. THE DISTRIBUTION OF MINUTE HEMOLYTIC STREPTOCOCCI IN NORMAL AND DISEASED HUMAN BEINGS.

Authors:  P H Long; E A Bliss; C F Walcott
Journal:  J Exp Med       Date:  1934-10-31       Impact factor: 14.307

6.  A SEROLOGICAL DIFFERENTIATION OF SPECIFIC TYPES OF BOVINE HEMOLYTIC STREPTOCOCCI (GROUP B).

Authors:  R C Lancefield
Journal:  J Exp Med       Date:  1934-03-31       Impact factor: 14.307

7.  A SEROLOGICAL DIFFERENTIATION OF HUMAN AND OTHER GROUPS OF HEMOLYTIC STREPTOCOCCI.

Authors:  R C Lancefield
Journal:  J Exp Med       Date:  1933-03-31       Impact factor: 14.307

  7 in total
  47 in total

1.  [Further studies on incidence and properties of hemolytic streptococci in inflammatory paradentopathies].

Authors:  U BERGER
Journal:  Z Hyg Infektionskr       Date:  1954

2.  [Hemolytic Streptococci in inflammatory paradentopathies].

Authors:  U BERGER
Journal:  Z Hyg Infektionskr       Date:  1953

Review 3.  Perinatal Group B Streptococcal Infections: Virulence Factors, Immunity, and Prevention Strategies.

Authors:  Jay Vornhagen; Kristina M Adams Waldorf; Lakshmi Rajagopal
Journal:  Trends Microbiol       Date:  2017-06-17       Impact factor: 17.079

4.  [Not Available].

Authors:  G B ROEMER
Journal:  Klin Wochenschr       Date:  1948-08-01

5.  [Streptokinase; its mode of action; possible clinical application].

Authors:  T HALSE
Journal:  Klin Wochenschr       Date:  1951-06-15

6.  The prospect of vaccination against group A beta-hemolytic streptococci.

Authors:  Karen L Kotloff
Journal:  Curr Infect Dis Rep       Date:  2008-05       Impact factor: 3.725

7.  Enhanced Postnatal Acquisition of Hypervirulent Group B Streptococcus.

Authors:  Adam J Ratner
Journal:  Clin Infect Dis       Date:  2019-10-30       Impact factor: 9.079

Review 8.  An unusual case of a large, sporadic intra-abdominal abscess due to group B Streptococcus and a review of the literature.

Authors:  N F Crum-Cianflone
Journal:  Infection       Date:  2014-09-27       Impact factor: 3.553

9.  Septicemia and endocarditis caused by group G streptococci in a Norwegian hospital.

Authors:  A Bucher; P Gaustad
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-04       Impact factor: 3.267

Review 10.  Group B Streptococcus vaccine: state of the art.

Authors:  Annalisa Nuccitelli; C Daniela Rinaudo; Domenico Maione
Journal:  Ther Adv Vaccines       Date:  2015-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.